Abstract Introduction: The American Thyroid Association appointed a Task Force of experts
to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the …

Background: Inherited and sporadic medullary thyroid cancer (MTC) is an uncommon and
challenging malignancy. The American Thyroid association (ATA) chose to create specific …

Neuroendocrine tumors (NETs) are rare neoplasms, which are characterized by the
presence of neuroamine uptake mechanisms and/or peptide receptors at the cell membrane …

Background Medullary thyroid carcinoma (MTC) is a malignant tumour derived from the para-
follicular thyroid C cells. It may occur in sporadic or hereditary forms and surgery represent …

Medullary thyroid carcinoma (MTC) arises from parafollicular or C cells that produce
calcitonin (CT), and accounts for 5–10% of all thyroid cancers. MTC is hereditary in about …

Purpose 18 F-FDG positron emission tomography (PET) value for the assessment of neuro-
endocrine tumours (NET) is limited. Preliminary studies indicate that 18 F-DOPA and 68 Ga …

Purpose: Because calcitonin level remains elevated after initial treatment in many medullary
thyroid carcinoma (MTC) patients without evidence of disease in the usual imaging work-up …

Purpose To retrospectively evaluate and compare 18 F-FDG, 18 F-DOPA and 68 Ga-
somatostatin analogues for PET/CT in patients with residual/recurrent medullary thyroid …

Medullary thyroid carcinoma (MTC) accounts for up to 8% of all thyroid cancers. Although
primary surgery is curative in the vast majority of patients treated at an early stage, disease …

Neuroendocrine tumours (NET) are rare tumours that occur most commonly in the GI tract.
Various labelled somatostatin analogues are used to image NET expressing somatostatin …